International Consortium of Research Excellence of the Theodor-Billroth-Academy®

The International Consortium of Research Excellence (INCORE) of the Theodor Billroth Academy® – TBA® is a global initiative dedicating to advancing translational research, scientific collaboration, and data-driven innovation.

By this, INCORE brings together leading researchers and institutions to address critical challenges in cancer research, medical sciences, humanitarian aid, education and training, as well as interdisciplinary research.

Exemplary involved colleagues as INCORE members are Ijaz S Jamall (Sacramento, CA, USA), Marijan Slak Rupnik (Vienna, Austria), Oliver Hayden (Munich, Germany), Björn Petersen (Mount Horeb, WI, USA), Aviram Nissan (Ramat Gan, Israel), Michael A Scherer (Munich, Germany), Avraham I Rivkind (Jerusalem, Israel), Mladjan Protic (Novi Sad, Sremska Kamenica, Serbia), Volkmar Weissig (Glendale, AZ, USA), Masaharu Seno (Okayama, Japan), Martin Daumer (Munich, Germany), Bruno Zilberstein (São Paulo, Brazil), Yoav Mintz (Jerusalem, Israel), Jose Florencio F Lapeña Jr. (Manila, Philippines), Ray Perkins (Owenton, KY, USA), Georgios Anogianakis (Thessaloniki, Greece), Jochen Salber (Bochum, Germany), Raimuno Araujo Jr. (Piauí, Brazil), José Manuel Correia da Costa (Porto, Portugal), Amir Szold (Tel Aviv, Israel), Lucio Lara Santos (Porto, Portugal), and many more.

Furthermore, INCORE drives forward-thinking research shaping the future, and supports scientific meetings of impact as well as collaborative projects. Knowledge exchange here is facilitated among scientists worldwide by global scientific collaboration.

The recitation number of INCORE publications continuously increases, and reached in 2025 already 2.000 + explaining its value and legacy. Here, some publications are single collaborations, some are part of a huge long-term ongoing conception.

One since 2012 created extremely complex huge and long term conception is Epistemology of the Origin of Cancer.

Epistemology of the Origin of Cancer I and II already contains various realized conceptions.

Concept 1 was defined 2012 and realized with 5 peer-reviewed and open-access publications between 2014 and 2016, and contains the cognition how the mass of cancers develop together with molecular cell signaling, knowledge in genomics, anticancer strategy and mutations.

(2014) Epistemology of the origin of cancer: a new paradigm, BMC Cancer 14(186), 1-15. 

(2014) Cell-Cell communication in tumor microenvironment, carcinogenesis and anticancer treatment, Cell Physiol Biochem 34(2), 213-243.

(2014) Imagine a World without Cancer, BMC Cancer 14(186), 1-8.

(2016)‎ Somatic Mutation Theory: Why it’s Wrong for Most Cancers, Cell Physiol Biochem 38(5), 1-18.

(2016) Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers. Clin Transl Med 5(1), 1-16.